低HER2三阴性乳腺癌的临床和分子特征:从多omics分析的见解

Yinlong Yang1, Liangwei Pan1, Wenzhe Zhou1

  • 1Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai, China; Department of Oncology, Fudan University, Shanghai Medical College, Shanghai, China.

Breast (Edinburgh, Scotland)
|September 24, 2025
PubMed
概括

低HER2三阴性乳腺癌 (TNBC) 与HER2-0 TNBC相比显示出不同的分子特征. 低HER2状况与光雌激素受体 (LAR) 亚型中更好的无复发生存率有关.